Yoshihiro Fujimura

11.4k total citations
249 papers, 8.1k citations indexed

About

Yoshihiro Fujimura is a scholar working on Hematology, Immunology and Nephrology. According to data from OpenAlex, Yoshihiro Fujimura has authored 249 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Hematology, 158 papers in Immunology and 61 papers in Nephrology. Recurrent topics in Yoshihiro Fujimura's work include Complement system in diseases (148 papers), Platelet Disorders and Treatments (122 papers) and Renal Diseases and Glomerulopathies (60 papers). Yoshihiro Fujimura is often cited by papers focused on Complement system in diseases (148 papers), Platelet Disorders and Treatments (122 papers) and Renal Diseases and Glomerulopathies (60 papers). Yoshihiro Fujimura collaborates with scholars based in Japan, United States and Switzerland. Yoshihiro Fujimura's co-authors include Masanori Matsumoto, Koiti Titani, Taei Matsui, Hideo Yagi, Akira Yoshioka, Toshiyuki Miyata, Hiromichi Ishizashi, Koichi Kokame, Ayami Isonishi and T S Zimmerman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Yoshihiro Fujimura

238 papers receiving 7.9k citations

Peers

Yoshihiro Fujimura
Steven A. Krilis Australia
Russell P. Rother United States
Scott A. Rollins United States
Francesco Tedesco Italy
X. Long Zheng United States
David Kavanagh United Kingdom
D. Robert Sutherland Canada
Leendert A. Trouw Netherlands
Monica Bessler United States
Falk Hiepe Germany
Steven A. Krilis Australia
Yoshihiro Fujimura
Citations per year, relative to Yoshihiro Fujimura Yoshihiro Fujimura (= 1×) peers Steven A. Krilis

Countries citing papers authored by Yoshihiro Fujimura

Since Specialization
Citations

This map shows the geographic impact of Yoshihiro Fujimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiro Fujimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiro Fujimura more than expected).

Fields of papers citing papers by Yoshihiro Fujimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshihiro Fujimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiro Fujimura. The network helps show where Yoshihiro Fujimura may publish in the future.

Co-authorship network of co-authors of Yoshihiro Fujimura

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshihiro Fujimura. A scholar is included among the top collaborators of Yoshihiro Fujimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshihiro Fujimura. Yoshihiro Fujimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kubo, M., Karoliina Könkö, Emiko Kinoshita, et al.. (2023). PB0318 Evaluation of a Novel ADAMTS13 Activity Reagent Using Fully Automated Analyzer. Research and Practice in Thrombosis and Haemostasis. 7. 101465–101465.
2.
Matsumoto, Masanori, Yoshitaka Miyakawa, Koichi Kokame, et al.. (2023). Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023. International Journal of Hematology. 118(5). 529–546. 15 indexed citations
3.
Fujimura, Yoshihiro. (2021). COVID-19-associated thrombotic microangiopathy (TMA). Japanese Journal of Thrombosis and Hemostasis. 32(3). 307–314.
4.
Kato, Hideki, Yoshitaka Miyakawa, Yoshihiko Hidaka, et al.. (2018). Safety and effectiveness of eculizumab for adult patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance. Clinical and Experimental Nephrology. 23(1). 65–75. 16 indexed citations
5.
Matsui, Taei, Akiko Hori, Jiharu Hamako, et al.. (2017). Mutant botrocetin‐2 inhibits von Willebrand factor‐induced platelet agglutination. Journal of Thrombosis and Haemostasis. 15(3). 538–548. 9 indexed citations
6.
Miyakawa, Yoshitaka, Kazunori Imada, Tatsuo Ichinohe, et al.. (2016). Efficacy and safety of rituximab in Japanese patients with acquired thrombotic thrombocytopenic purpura refractory to conventional therapy. International Journal of Hematology. 104(2). 228–235. 16 indexed citations
7.
Kagami, Shoji, Hirokazu Okada, Shinya Kaname, et al.. (2012). [Diagnostic criteria of atypical hemolytic uremic syndrome].. PubMed. 2(2). 91–3. 3 indexed citations
8.
Yamashita, Atsushi, Kensaku Nishihira, Yunosuke Matsuura, et al.. (2012). Paucity of CD34-positive cells and increased expression of high-mobility group box 1 in coronary thrombus with type 2 diabetes mellitus. Atherosclerosis. 224(2). 511–514. 24 indexed citations
9.
Nakagawa, Terumichi, Takanori Moriki, Yusuke Yamaguchi, et al.. (2012). Identification of epitopes on ADAMTS13 recognized by a panel of monoclonal antibodies with functional or non-functional effects on catalytic activity. Thrombosis Research. 130(3). e79–e83. 5 indexed citations
10.
Kato, Seiji, et al.. (2010). DEVELOPMENT OF ADAMTS13 ACTIVITY ELISA KIT AND EVALUATION OF ITS PERFORMANCE. Japanese Journal of Transfusion and Cell Therapy. 56(1). 27–35. 1 indexed citations
11.
Zakarija, Anaadriana, Hau C. Kwaan, Joel L. Moake, et al.. (2009). Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989–2008). Kidney International. 75(112). S20–S24. 60 indexed citations
12.
Yagi, Hideo, Masanori Matsumoto, & Yoshihiro Fujimura. (2007). Brain Nerve Symptoms due to Thrombotic Microangiopathy. Nihon Naika Gakkai Zasshi. 96(2). 353–362. 1 indexed citations
13.
Fujimura, Yoshihiro, Masanori Matsumoto, Hideo Yagi, et al.. (2002). von Willebrand Factor—Cleaving Protease and Upshaw-Schulman Syndrome. International Journal of Hematology. 75(1). 25–34. 70 indexed citations
14.
Ueda, Shiro, Kenji Nishio, Naoto Minamino, et al.. (1999). Increased Plasma Levels of Adrenomedullin in Patients with Systemic Inflammatory Response Syndrome. American Journal of Respiratory and Critical Care Medicine. 160(1). 132–136. 157 indexed citations
15.
Kawasaki, Tomihisa, Yoshihiro Fujimura, Yoshiko Usami, et al.. (1996). Complete Amino Acid Sequence and Identification of the Platelet Glycoprotein Ib-binding Site of Jararaca GPIb-BP, a Snake Venom Protein Isolated from Bothrops jararaca. Journal of Biological Chemistry. 271(18). 10635–10639. 62 indexed citations
16.
Fujimura, Yoshihiro, Nobuhiro Narita, Taei Matsui, et al.. (1995). ABO Blood Group Genotype and Plasma von Willebrand Factor in Normal Individuals. Vox Sanguinis. 68(4). 236–240. 88 indexed citations
17.
Nishida, Sachiyo, Taketo Shimoyama, Yoshihiro Fujimura, et al.. (1994). A case of hydrops foetalis found in a pregnant woman with low-titer anti-Jra antibody: with consideration of the associated chronic hemolytic anemia and left heart hypoplasia.. Journal of the Japan Society of Blood Transfusion. 40(1). 95–100. 1 indexed citations
18.
Nishimura, Takuya, et al.. (1992). The ABO-blood group genotype in Japanese determined by polymerase chain reaction (PCR) using genomic DNA.. Journal of the Japan Society of Blood Transfusion. 38(4). 542–547. 2 indexed citations
19.
Fujimura, Yoshihiro, et al.. (1982). Studies on Vitamin K-Dependent Factor Deficiency during Early Childhood with Special Reference to Prothrombin Activity and Antigen Level. Pathophysiology of Haemostasis and Thrombosis. 11(2). 90–95. 7 indexed citations
20.
Fujimura, Yoshihiro. (1979). Studies on Factor 8 Procoagulant Activity(8:C):Its Purification and Some Biochemical Properties. 30(4). 199–212.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven A. Krilis Breakdown of academic impact, for papers by Russell P. Rother Breakdown of academic impact, for papers by Scott A. Rollins Breakdown of academic impact, for papers by Francesco Tedesco Breakdown of academic impact, for papers by X. Long Zheng Breakdown of academic impact, for papers by David Kavanagh Breakdown of academic impact, for papers by D. Robert Sutherland Breakdown of academic impact, for papers by Leendert A. Trouw Breakdown of academic impact, for papers by Monica Bessler Breakdown of academic impact, for papers by Falk Hiepe
Rankless by CCL
2026